The total size of the offering was $130,000,000 based on an initial share price of $20.00. The official website for 908 Devices is www.908devices.com. IPO News. All rights reserved. Get the latest coverage on companies entering the stock market. To see all exchange delays and terms of use please see disclaimer. The latest information on initial public offerings (IPOs), including latest IPOs, expected IPOs, recent filings, and IPO performance from Nasdaq. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. Vote “Outperform” if you believe MASS will outperform the S&P 500 over the long term. First Mass. The Week's Top Stories: Disney Plus, Pot Meme Stocks, Bumble IPO In this Nov. 13, 2019 file photo, a Disney logo forms part of a menu for the Disney Plus movie and entertainment streaming service on a computer screen in Walpole, Mass. On average, they expect 908 Devices' share price to reach $69.67 in the next twelve months. 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for 908 Devices in the last year. Our subscription-based services provide access to a wealth of IPO and secondary equity offerings data, reports and statistics. Currently, 1.0% of the shares of the company are sold short. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. loanDepot IPO Future Timing And Stock Price A Good Bet LDI • Fri, Feb. 5, 12:02 PM • Noah Wilson • 6 Comments Adagene Readies Plan For $132 Million U.S. IPO From the pre-Pandemic closing high on February 20, 2020, to the closing high on February 12, 2021, the ETF surged 117% (stock data via Ycharts): TRUTH LIVES on at https://sgtreport.tv/ The ETF tracks the Renaissance IPO index, which reflects the top 80% of companies by capitalization that went public over the past two years. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. Their forecasts range from $65.00 to $74.00. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. This is +106% more than in 2019 with 233 IPOs. Could Eastern Bank's IPO Prompt a Wave of Mutual Savings Bank Demutualizations? There are fewer partners for mutual savings banks to merge with, and it's … View analyst ratings for 908 Devices or view top-rated stocks. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. 908 Devices Inc. (MASS) Prices 6.5M Share IPO at $20/Share Article Related Press Releases ( 1 ) Stock Quotes (1) FREE Breaking News Alerts from StreetInsider.com! Real-time trade and investing ideas on MasterCard Incorporated MA from the largest community of traders and investors. Vote “Underperform” if you believe MASS will underperform the S&P 500 over the long term. 908 Devices has only been the subject of 4 research reports in the past 90 days. As readers will note below, IPOs in the biotech space can surge over 300% within just a year or two. 908 Devices employs 96 workers across the globe. 908 Devices saw a drop in short interest in February. Find the latest 908 Devices Inc. (MASS) stock quote, history, news and other vital information to help you with your stock trading and investing. Mass Index: A form of technical analysis that examines the range between high and low stock prices over a period of time. 10 minutes ago - TransCode Therapeutics Starts $29 Million IPO Effort - Seeking Alpha 9 hours ago - Roblox IPO: 3 Reasons the Gaming Platform Is More Than Just Hype - The Motley Fool 1 day ago - U.S. IPO Week Ahead: Korean E-Commerce And Online Gaming Lead A 5 IPO, 1 Direct-Listing Week - Seeking Alpha 2 days ago - Online learning platform Coursera files for U.S. IPO - Reuters They will enable the company to pay its executives fairly low wages up front. The Historical Biotech IPO Database below tracks most listings over at least the previous 12 months. View our full suite of financial calendars and market data tables, all for free. An initial public offering (IPO), sometimes called a flotation, is a sale of a company's securities to the investing public on a stock exchange. During the company's quiet period, underwriters and any insiders involved in the IPO were prevented from issuing any research reports for the company because of regulations issued by the Securities and Exchange Commission. 908 Devices had issued 6,500,000 shares in its public offering on December 18th. Export data to Excel for your own analysis. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Get short term trading ideas from the MarketBeat Idea Engine. Learn more. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Get the latest news and real-time alerts from 908 Devices Inc. (MASS) stock at Seeking Alpha. Get daily stock ideas top-performing Wall Street analysts. In the past three months, 908 Devices insiders have bought more of their company's stock than they have sold. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company. Please contact us here http://www.streetinsider.com/signup_content.php. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings. MarketBeat's community ratings are surveys of what our community members think about 908 Devices and other stocks. This suggests a possible upside of 62.8% from the stock's current price. Do Not Sell My Information. (Add your “outperform” vote. 908 Devices will be holding an earnings conference call on Tuesday, March 30th at 12:00 AM Eastern. (MASS) raised $101 million in an initial public offering (IPO) on Friday, December 18th 2020. Company insiders that own 908 Devices stock include E Kevin Hrusovsky, Michael S Turner and Venture Fund Vii LP Arch. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. 908 Devices is scheduled to release its next quarterly earnings announcement on Tuesday, March 30th 2021. Zero Mass Water Stock. View institutional ownership trends for 908 Devices. If you have funds in another currency the cheapest way to convert your currency is to use the mid-market rate (that’s the one you’ll find on Google) which can be done via a fintech service like Wise. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. ... when a recession-hobbled economy eked out just 63 initial public offerings of stock. The BioPharmCatalyst Biotech Stock IPO Calendar gives a brief rundown of upcoming biotech initial public offerings. Identify stocks that meet your criteria using seven unique stock screeners. You reached this page when attempting to access https://www.streetinsider.com/Corporate+News/908+Devices+Inc.+%28MASS%29+Prices+6.5M+Share+IPO+at+%2420Share/17736696.html from 54.39.145.137 on 2021-03-10 13:55:47 UTC. Date Company name ISIN code Location Market; 04/03/2021: HAV GROUP: NO0010931918 : Oslo : Euronext Growth : 03/03/2021: COIMBRA VIVA I Want to see which stocks are moving? You may vote once every thirty days. One share of MASS stock can currently be purchased for approximately $42.80. Its products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. Initial public offerings (IPO), the first time that the stock of a private company is sold to the public, got a little crazy in the dotcom mania days of the 1990s. The latest news coverage on initial public offerings, or IPOs, from MarketWatch. IPO Monitor provides comprehensive coverage of IPOs and Secondary Equity Offerings. Wall Street analysts have given 908 Devices a "Buy" rating, but there may be better short-term opportunities in the market. View which stocks are hot on social media with MarketBeat's trending stocks report. Cowen, SVB Leerink, Stifel and William Blair acted as the underwriters for the IPO. Some companies that are related to 908 Devices include Convatec Group (CTEC), Butterfly Network (BFLY), Stratec (SBS), Drägerwerk AG & Co. KGaA (DRW3), Avacta Group (AVCT), Viemed Healthcare (VMD), Viemed Healthcare (VMD), Itamar Medical (ITMR), Creo Medical (CREO), Talis Biomedical (TLIS), Titan Medical (TMD), Xtant Medical (XTNT), Hamilton Thorne (HTL), Medica Group (MGP) and Advanced Oncotherapy (AVO). Shares of 908 Devices soared as much as 164% in their market debut and closed at $49.03, up 145.1%, in one of the last traditional initial public offerings of the year. 908 Devices does not have a long track record of dividend growth. (MASS) raised $101 million in an IPO on Friday, December 18th 2020. As of February 12th, there was short interest totaling 92,200 shares, a drop of 70.0% from the January 28th total of 307,100 shares. (Add your “underperform” vote.). Shares of MASS can be purchased through any online brokerage account. 908 Devices stock indicated to open around $42.00, or 110% above $20 IPO price Dec. 18, 2020 at 11:05 a.m. http://www.streetinsider.com/signup_content.php. Based on an average trading volume of 381,900 shares, the days-to-cover ratio is presently 0.2 days. lost public companies and saw few IPOs in 2016 . Some acquired banks may have mulled an IPO if the right merger partner hadn’t come along, experts say. The company issued 6,300,000 shares at a price of $15.00-$17.00 per share. Het Interprovinciaal Overleg (IPO) is de belangenbehartiger van de twaalf provincies. Please log in to your account or sign up in order to add this asset to your watchlist. MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. 908 Devices has received a consensus rating of Buy. You can opt out at any time. The consensus among Wall Street analysts is that investors should "buy" 908 Devices stock. 908 Devices Inc. develops and sells measurement devices for chemical and biochemical analysis in the United States, China, Japan, Europe, and internationally. Cowen, SVB Leerink, Stifel and William Blair acted as the underwriters for the IPO. After completing the CAPTCHA below, you will immediately regain access to www.streetinsider.com. © American Consumer News, LLC dba MarketBeat® 2010-2021. Learn which companies are planning to go public soon, and when they are scheduling their IPOs. EquityZen is a marketplace for shares of proven pre IPO tech companies. Drinking water is a fundamental human right. 4 Wall Street analysts have issued 1 year price targets for 908 Devices' stock. View More Companies. Learn more. There are currently 4 buy ratings for the stock. It is also 20% higher than the previous record IPO year of 2000, which had 397. The Mass Index, developed … 908 Devices does not currently pay a dividend. The company issued 6,300,000 shares at $15.00-$17.00 per share. At Zero Mass, they make products that ensure that right. | NYSE, NASDAQ & AMEX Receive a free world-class investing education from MarketBeat. View all of MASS's competitors. 3 Explosive IPO Stocks to Buy in 2021 Keith Noonan, Joe Tenebruso, and Jamal Carnette, CFA 1/24/2021 Rural Americans in pharmacy deserts hurting for Covid-19 vaccines Fundamental company data provided by Zacks Investment Research. The company develops its products using mass spectrometry (Mass Spec) technology, an analytical technique for molecular analysis. Learn about financial terms, types of investments, trading strategies and more. JavaScript needs to be enabled to complete CAPTCHA. 908 Devices Inc. was founded in 2012 and is headquartered in Boston, Massachusetts. It offers handheld and desktop Mass Spec devices for the point-of-need applications in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. There were 480 IPOs on the US stock market in 2020, an all-time record. tech IPO of 2021 alert: Shares of Burlington agritech company Agrify Corp. soared over 30% in their first day of trading. Sign-up to receive the latest news and ratings for MASS and its competitors with MarketBeat's FREE daily newsletter. A sortable list of stocks which had Initial Public Offerings in the last year: 2020 - 2021. Top institutional investors include Tao Capital Management LP (2.73%), Price T Rowe Associates Inc. MD (2.19%), Sands Capital Management LLC (1.50%), Primecap Management Co. CA (1.24%), BlackRock Inc. (1.14%) and Lord Abbett & CO. LLC (0.57%). MASS stock was bought by a variety of institutional investors in the last quarter, including Tao Capital Management LP, Price T Rowe Associates Inc. MD, Sands Capital Management LLC, Primecap Management Co. CA, BlackRock Inc., Lord Abbett & CO. LLC, Pura Vida Investments LLC, and Nicholas Investment Partners LP. The Coinbase IPO and stock trading currency will be USD. 10 stocks we like better than Airbnb, Inc. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Id IPO Name Start Date End Date ; 1284: Easy Trip Planners Limited: 08 Mar 2021: 10 Mar 2021: Live Subscription: Details: 1283: MTAR Technologies Limited: 03 Mar 2021 As you were browsing www.streetinsider.com something about your browser made us think you were a bot. ), 908 Devices has received 0 “underperform” votes. View insider buying and selling activity for 908 Devices or or view top insider-buying stocks. 908 Devices has received 100.00% “outperform” votes from our community. Learn everything you need to know about successful options trading with this three-part video course. Profile | Reuters, 908 Devices prices IPO above range at $20, Research device developer 908 Devices raises range to $18 to $19 ahead of $116 million IPO, 908 Devices Raises $130 Million in What May Be the Last IPO of 2020, 908 Devices prices upsized IPO at $20, above the upwardly revised range, view top-rated stocks among Wall Street analysts, Receive Analysts' Upgrades and Downgrades Daily. Interested parties can register for or listen to the call using this link or dial in at Not Available. See what's happening in the market right now with MarketBeat's real-time news feed. Company insiders that have bought 908 Devices stock in the last two years include E Kevin Hrusovsky, Michael S Turner, and Venture Fund Vii LP Arch. The IPO also allows the company to attract top talent because it can offer stock options. Top IPO Stocks To Buy [Or Avoid] In December: C3.ai Inc. Software company C3.ai (AI Stock Report) is another hot IPO stock making big moves this week. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. In return, they have the promise that they can cash out later with the IPO. MarketBeat just released five new trading ideas, but 908 Devices wasn't one of them. Het IPO biedt tevens een platform aan de provincies voor het stimuleren van innovatie en de uitwisseling van kennis. 3 Hot IPO Stocks to Buy in December Find out why these stock market newcomers could deliver incredible returns. 908 Devices trades on the NASDAQ under the ticker symbol "MASS.". 908 Devices' management team includes the following people: Start Your Risk-Free Trial Subscription Here, Russia to make Sputnik V vaccine in Italy; a 1st in EU, Technology rebound leads stocks higher on Wall Street, Anheuser-Busch Inbev Stock is a Must Own Re-Opening Play, GE, AerCap join air leasing businesses in $30 billion deal, ChargePoint Stock is a Speculative EV Play Only for the Nimble and Risk-Tolerant, US officials: report on oil and gas sale ban due by summer, FlexShopper Stock: Small Price, Big Upside, Casey's General Stores is Still a Good Buy, Why Visa (NYSE:V) Stock Deserves More Credit, Thor Industries (NYSE:THO) Deserves A Spot In Your Pantheon Of Stocks, Texas Roadhouse Looks Like a Post-Pandemic Winner, Purple Innovation Attempts Rebound After Earnings Dive, Great Time to Buy Goodyear Tires (NYSE: GT) Stock Here, 7 Internet of Things Stocks That Are a Perfect Fit to Our Connected Future, 7 Undervalued Stocks That Deserve More Attention, 7 Semiconductor Stocks Set to Gain From the Chip Shortage, 7 Great Dividend Stocks to Buy For a Comfortable Retirement, 7 Penny Stocks That Don’t Care About Robinhood, 7 Hotel Stocks Just Waiting For the Vaccine, 7 Stocks to Watch When Student Debt Forgiveness Gets Passed, 7 Healthcare Stocks Delivering Innovation in 2021, 7 Lithium Stocks That Will Power the Electric Vehicle Boom, 7 Electric Vehicle (EV) Stocks That Have Real Juice, 908 Devices to Report Fourth Quarter and Full Year 2020 Financial Results on March 30, 2021, 908 Devices to Participate in Upcoming Investor Conferences, 908 Devices Strengthens Commercial Team with Addition of New Vice President, MASS.OQ - 908 Devices Inc. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. View 908 Devices' Short Interest. If you are interested in www.streetinsider.com content, APIs are available. Specifically, they have bought $7,100,000.00 in company stock and sold $0.00 in company stock. Looking for new stock ideas? The company can be reached via phone at 857 254 1500. View our earnings forecast for 908 Devices. IPO Stocks Can Form Multiple Bases The stock didn't create its first regular base until October 2012 to April 2013, when ServiceNow fell from a 41.77 peak to a low of 25.54, a 39% correction. 908 Devices' quiet period expired on Wednesday, January 27th. 908 Devices' stock is owned by a number of retail and institutional investors. Compare Top Brokerages Here. Buy or sell Zero Mass Water stock pre IPO via an EquityZen fund. According to analysts' consensus price target of $69.67, 908 Devices has a forecasted upside of 62.8% from its current price of $42.80. Request Access. Mass. 908 Devices has received 4 “outperform” votes. Earnings for 908 Devices are expected to decrease in the coming year, from ($0.40) to ($0.53) per share. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 View analysts' price targets for 908 Devices or view top-rated stocks among Wall Street analysts. When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. 908 Devices has a market capitalization of $1.12 billion.